Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study

被引:18
作者
Narducci, Filomena [1 ]
Grande, Roberta [1 ]
Mentuccia, Lucia [1 ]
Trapasso, Tiziana [1 ]
Sperduti, Isabella [2 ]
Magnolfi, Emanuela [1 ]
Fariello, Anna Maria [1 ]
Gemma, Donatello [1 ]
Gamucci, Teresa [1 ]
机构
[1] Osped SS Trinita, Med Oncol Unit, Sora, Asl Frosinone, Italy
[2] Regina Elena Inst Canc Res, Biostat Unit, Rome, Italy
关键词
Palliative care; Prognostic score; Survival; Advanced cancer; ASSESSMENT SCALE; VALIDATION; QUALITY; SCORE; LIFE; ESAS; END;
D O I
10.1007/s00520-011-1207-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Edmonton Symptom Assessment Scale (ESAS) is a validated tool for physical symptom assessment in palliative care practice which evaluates symptoms through a numeric scale from 0 to 10. The use of symptom improvement as a prognostic factor is controversial. To this purpose, a pilot study in advanced cancer patients now undergoing only palliative care was conducted. Patients were considered eligible if no longer able to receive any anticancer treatment; they were scheduled to undergo ESAS assessment at the hospitalization and hospital discharge time points. Symptoms' scores were divided into three severity classes: mild, moderate and severe. Differences across symptoms' classes between hospitalization and hospital discharge time points were analysed with the paired-data McNemar test, according to tumour types. ESAS assessment was administered to 68 patients with gastrointestinal (39 patients) and non-small cell lung cancer (29 patients); median age was 69 years; Karnofsky Performance Status was 50 in 27 (39.7%) patients and > 50 in 41 (60.3%) patients. Palliative Prognostic Score was A for 26 (38.2%) patients, B for 37 (54.4%) patients and C for 5 (7.4%) patients. A statistically significant reduction of severe severity class rates was observed. Symptom improvement correlates with survival improvement: Palliative Prognostic Score (hazard ratio (HR) 2.95, 95% CI 1.35-6.41, p = 0.006) and anorexia (HR 3.21, 95% 1.33-7.72, p = 0.009) appear to be prognostic factors for survival at the multivariate analysis for gastrointestinal cancer patients; asthenia is the only significant variable (HR 5.11, 95% CI 1.86-14.03, p = 0.002) for non-small cell lung cancer patients. Symptom improvement according to ESAS after palliative care treatment represents an important prognostic for survival in patients no longer suitable to receive any anticancer active therapies.
引用
收藏
页码:1221 / 1226
页数:6
相关论文
共 23 条
[1]  
Bruera E, 1991, J Palliat Care, V7, P6
[2]  
Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO
[3]  
2-5
[4]  
Cohen S R, 1992, J Palliat Care, V8, P40
[5]   The Edmonton Symptom Assessment Scale (ESAS) as an audit tool [J].
Dudgeon, DJ ;
Harlos, M ;
Clinch, JJ .
JOURNAL OF PALLIATIVE CARE, 1999, 15 (03) :14-19
[6]   Identifying potential indicators of the quality of end-of-life cancer care from administrative data [J].
Earle, CC ;
Park, ER ;
Lai, B ;
Weeks, JC ;
Ayanian, JZ ;
Block, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1133-1138
[7]   Trends in the aggressiveness of cancer care near the end of life [J].
Earle, CC ;
Neville, BA ;
Landrum, MB ;
Ayanian, JZ ;
Block, SD ;
Weeks, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :315-321
[8]   QUALITY-OF-LIFE ASSESSMENT IN PALLIATIVE CARE [J].
FINLAY, IG ;
DUNLOP, R .
ANNALS OF ONCOLOGY, 1994, 5 (01) :13-18
[9]  
Giannini M, 2004, PALLIATIVE MED, V18, P389
[10]   Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service [J].
Glare, P ;
Virik, K .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (05) :891-898